The Annual Inter-Academy Seoul Science Forum will be held on November 1st through the 2nd. The Forum is hosted by The Korean Academy of Science and Technology (KAST). It will be the greatest Forum to date after the foundation of KAST. Many Noble Prize winners will be speakers and many renowned doctors will attend. Also, the representatives of KAST will
Notice
BIOCON-ETC Joint Workshop 안내입니다. ———————————————– ㅇ 일시 : 2012.10.15(월) 13:00-18:00 ㅇ 장소 : 융기원 1층 A103호 ———————————————— Singapore 의 “Experimental Therapeutics Centre” 의 CEO 인 Alex Matter씨가 방문하여 BIOCON과 Joint Workshop을 진행합니다. 많은 관심과 참여바랍니다.
Last August, Dr. Tae Hee Kang’s article was selected for the cover of JMB (Journal of Molecular Biology) Volume 423, Issue4, November 2012. “AIMP3/p18 Controls Translational Initiation by Mediating the Delivery of Charged Initiator tRNA to Initiation Complex” can be found on page 475-481. Also, the article was chosen as Featured Communication, and its Commentary was published. For more details,
Dr. Kang’s publication was chosen as the featured communication article in JMB called “AIMP3/p18 Controls Translational Initiation by Mediating the Delivery of Charged Initiator tRNA to Initiation Complex.” Commentary about the article can be seen in JMB as well. For more details, please visit http://www.biocon.re.kr/28819.
Dr. Min Guo from Scripps and Dr. Ehud Razin from Hebrew University collaborated with Bicon regarding KRS, and its article got an approval to be published in Molecular Cell. The title is “Structural Switch of Lysyl-tRNA Synthetase between Translation and Transcription.”
The article written by Professor Sunghoon Kwon (Biocon PI) was chosen as the front cover of Advanced Materials. The article is about QR coded microparticle that can detect quack medicines when injected. More details will be informed.
On august 4th, the article written by Doctor Tae hee Kang was selected as the front cover art of JMB (Journal of Molecular Biology). The final cover of the article will be noticed when published. Its title is “AIMP3/p18 Controls Translational Initiation by Mediating the Delivery of Charged Initiator tRNA toInitiation Complex.” Please visit http://www.biocon.re.kr/28819 for more details.
Director Sunghoon Kim will be awarded from the National Academic of Sciences. Date: 9. 17. 2012 Place: The National Academic of Sciences, conference room (2nd floor) Time: 14:00~15:00
2012 BioKorea will be held from 12th to 14th in Kintex. On 14th, Biocon will host Medicinal Bio-Convergence. On that day, Director Sunghoon Kim will give a speech about ” A role of universities in discovering new medicines.”
교육과학기술부는 기존 기술의 한계를 돌파하는 세계최고의 원천기술 개발을 목표로 ‘글로벌프론티어사업’을 추진하고 있으며, 본 사업의 한 분야인 ‘혁신형 의약바이오컨버젼스연구’를 서울대학교 (재)의약바이오컨버젼스연구단에서 수행중에 있습니다. 이와 관련하여 2012년도 혁신형 의약바이오컨버젼스 연구분야의 신규 세부과제를 공모하오니 신청하여 주시기 바랍니다. □ 공모개요 ○ 지원대상: 국가 연구 과제 수행에 결격 사유가 없는 자 ○ 연구기간: 년 단위로 심사 후 업적 평가 및 지원여부 결정 ○ 공모기간: 2012년